Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RNASEL | Q05823 | 8/20 | 0.56 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.55 |
| ▸ | TGM2 | P21980 | 1/20 | 0.55 |
| ▸ | DTYMK | P23919 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23477159 | 1.00 | RNASEL (0.56) | RNASELFUT5TGM2DTYMK | |
| SCHEMBL19696038 | 0.95 | RNASEL (0.61) | RNASEL | |
| SCHEMBL25552773 | 0.95 | TGM2 (0.60) | RNASELFUT5TGM2 | |
| SCHEMBL23477028 | 0.93 | FUT5 (0.58) | RNASELFUT5TGM2 | |
| SCHEMBL27378469 | 0.92 | RNASEL (0.67) | RNASELTGM2 | |
| SCHEMBL25851327 | 0.92 | TGM2 (0.52) | RNASELFUT5TGM2DTYMK | |
| SCHEMBL22352060 | 0.92 | RNASEL (0.65) | RNASEL | |
| SCHEMBL19696031 | 0.91 | DTYMK (0.62) | RNASELDTYMK | |
| SCHEMBL20341101 | 0.91 | RNASEL (0.58) | RNASEL | |
| SCHEMBL20762949 | 0.91 | DNPH1 (0.55) | RNASELFUT5DTYMK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220389032-A1 | BENZOTHIOPHENE, THIENOPYRIDINE AND THIENOPYRIMIDINE DERIVATIVES FOR THE MODULATION OF STING | CTXT PTY LTD. (AU) | 2022-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220389032-A1 | BENZOTHIOPHENE, THIENOPYRIDINE AND THIENOPYRIMIDINE DERIVATIVES FOR THE MODULATION OF STING | STING1, CGAS, MAVS | RNASEL 3509/4885FUT5 4825/4885TGM2 3744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.